Trial intelligence / Profile preview

Induction chemotherapy followed by chemoradiotherapy in locally advanced hypopharyngeal carcinoma

NCT04502641Phase 3Unknown

Sponsor
Sun Yat-sen University
Start
Aug 2020
Primary completion
Aug 2023
Modality
Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of docetaxel, Cisplatin micelle injection (HA132), fluorouracil in hypopharyngeal squamous cell carcinoma (HSCC), sponsored by Sun Yat-sen University. Status: unknown.

02

Drugs

docetaxelCisplatin micelle injection (HA132)fluorouracil
03

Conditions

hypopharyngeal squamous cell carcinoma (HSCC)

Beyond the preview

Go deeper on NCT04502641.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04502641.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call